Evidence map›Paper›PMID 28253216›Full record

SynthesisJournal of hypertension2017

White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.

Yuli Huang, Weijun Huang, Weiyi Mai, Xiaoyan Cai, Dongqi An, Zhuheng Liu, He Huang, Jianping Zeng, Yunzhao Hu, Dingli Xu

Open access · greenAbstract readMeta-AnalysisReview
In one paragraph

Synthesis in Journal of hypertension, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed, 11 pooled it
16.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 11 syntheses or guidelines pooled it, 201 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Cardiovascular frailty - an emerging frailty phenotype.Journal of human hypertension · 2026
    Review
  14. Article
  15. Observational
  16. Article
  17. Brazilian Guidelines of Hypertension - 2025.Arquivos brasileiros de cardiologia · 2025
    Article
  18. Article
  19. Article
  20. Article

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Yuli HuangaDepartment of Cardiology, Nanfang Hospital, Southern Medical University, GuangzhoubDepartment of Cardiology, The Affiliated Hospital at Shunde (the First People's Hospital of Shunde), Southern Medical UniversitycDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, GuangzhoudDepartment of Cardiology, the Central Hospital of Xiangtan, Xiangtan, PR China.
Weijun Huang
Weiyi Mai
Xiaoyan Cai
Dongqi An
Zhuheng Liu
He Huang
Jianping Zeng
Yunzhao Hu
Dingli Xu
Apple (Israel) · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhether white-coat hypertension (WCH) is an innocent phenomenon is controversial.

methodIn this study, we evaluated the association of WCH and the risk of cardiovascular diseases (CVDs) and mortality, stratified by baseline antihypertensive treatment status. Databases (PubMed, EMBASE, CINAHL Plus, Scopus, and Google Scholar) were searched for prospective studies with data on CVD and total mortality associated with WCH. The primary outcomes were the risk of CVD and total mortality associated with WCH stratified by antihypertensive treatment status. The relative risks of events compared with normotension were calculated.

resultsA total of 23 cohorts (20 445 individuals), 11 cohorts (8656 individuals), and 12 cohorts (21 336 individuals) were included for analysis of cardiovascular risk associated with WCH in patients without baseline antihypertensive treatment (untreated), or under antihypertensive treatment (treated) or mixed population (including both untreated and treated patients), respectively. In untreated cohorts, WCH was associated with a 38 and 20% increased risk of CVD and total mortality compared with normotension, respectively. In the mixed population, WCH was associated with a 19 and 50% increased risk of CVD and total mortality. However, in the treated patients, neither the risk of CVD, nor total mortality was increased in WCH. Meta-regression analyses indicated that neither differences of clinic blood pressure, nor out-of-office blood pressure variables were correlated with risk of CVD in WCH.

conclusionWe concluded that WCH is associated with long-term risk of CVD and total mortality in patients without antihypertensive treatment. Close follow-up should be performed in WCH patients.

Indexed as

AdultAgedAged, 80 and overCardiovascular DiseasesFemaleHumansMaleMiddle AgedRisk FactorsWhite Coat Hypertension

Identifiers

PMID28253216
PMCPMC5338886
OpenAlexW2568104734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.